Erste Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $93.5K | Sell |
190
-2,942
| -94% | -$1.09M | ﹤0.01% | 569 |
|
|
2026
Q1 | $931K | Sell |
3,132
-376
| -11% | -$124K | 0.01% | 448 |
|
|
2025
Q4 | $1.25M | Sell |
3,508
-1,503
| -30% | -$508K | 0.01% | 413 |
|
|
2025
Q3 | $1.63M | Sell |
5,011
-8,193
| -62% | -$2.55M | 0.02% | 365 |
|
|
2025
Q2 | $5.04M | Buy |
13,204
+11,284
| +588% | +$4.54M | 0.04% | 275 |
|
|
2025
Q1 | $830K | Sell |
1,920
-338
| -15% | -$136K | 0.01% | 392 |
|
|
2024
Q4 | $837K | Buy |
2,258
+390
| +21% | +$163K | 0.01% | 404 |
|
|
2024
Q3 | $978K | Buy |
1,868
+145
| +8% | +$77.5K | 0.01% | 388 |
|
|
2024
Q2 | $925K | Sell |
1,723
-165
| -9% | -$87.2K | 0.01% | 379 |
|
|
2024
Q1 | $981K | Buy |
1,888
+110
| +6% | +$54.7K | 0.01% | 369 |
|
|
2023
Q4 | $833K | Buy |
1,778
+289
| +19% | +$134K | 0.01% | 385 |
|
|
2023
Q3 | $663K | Hold |
1,489
| – | – | 0.01% | 379 |
|
|
2023
Q2 | $656K | Sell |
1,489
-7,141
| -83% | -$3.29M | 0.01% | 396 |
|
|
2023
Q1 | $3.96M | Sell |
8,630
-288
| -3% | -$137K | 0.08% | 234 |
|
|
2022
Q4 | $4.57M | Buy |
8,918
+416
| +5% | +$211K | 0.1% | 214 |
|
|
2022
Q3 | $3.88M | Sell |
8,502
-10,239
| -55% | -$4.9M | 0.09% | 227 |
|
|
2022
Q2 | $9.1M | Buy |
18,741
+11,190
| +148% | +$5.54M | 0.2% | 135 |
|
|
2022
Q1 | $3.79M | Sell |
7,551
-112
| -1% | -$51.2K | 0.07% | 248 |
|
|
2021
Q4 | $3.58M | Buy |
7,663
+36
| +0.5% | +$15.1K | 0.06% | 246 |
|
|
2021
Q3 | $2.96M | Sell |
7,627
-350
| -4% | -$133K | 0.06% | 250 |
|
|
2021
Q2 | $3.04M | Sell |
7,977
-556
| -7% | -$212K | 0.06% | 253 |
|
|
2021
Q1 | $3.11M | Buy |
8,533
+260
| +3% | +$83.6K | 0.08% | 224 |
|
|
2020
Q4 | $2.6M | Buy |
8,273
+793
| +11% | +$243K | 0.07% | 239 |
|
|
2020
Q3 | $1.95M | Buy |
7,480
+1,350
| +22% | +$363K | 0.07% | 250 |
|
|
2020
Q2 | $1.59M | Sell |
6,130
-480
| -7% | -$128K | 0.06% | 255 |
|
|
2020
Q1 | $1.52M | Sell |
6,610
-860
| -12% | -$234K | 0.09% | 209 |
|
|
2019
Q4 | $2.29M | Buy |
7,470
+100
| +1% | +$27.5K | 0.1% | 196 |
|
|
2019
Q3 | $1.75M | Hold |
7,370
| – | – | 0.09% | 201 |
|
|
2019
Q2 | $2.08M | Hold |
7,370
| – | – | 0.11% | 169 |
|
|
2019
Q1 | $2.08M | Buy |
7,370
+70
| +1% | +$20.2K | 0.12% | 172 |
|
|
2018
Q4 | $1.9M | Buy |
+7,300
| New | +$2.01M | 0.13% | 158 |
|
Other funds holding ELV
Erste Asset Management's ELV Position: Q2 2026 in Review
Erste Asset Management reduced its Elevance Health (ELV) stake by 94% in Q2 2026, selling an estimated $1.09M and leaving 190 shares worth $93.5K. The position accounts for ﹤0.01% of the portfolio, ranked #569.
Erste Asset Management first reported a position in ELV in Q4 2018 and has held it in 31 quarters since. The position peaked at $9.1M in Q2 2022. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Erste Asset Management held 190 shares of Elevance Health worth $93.5K as of Q2 2026.
- Erste Asset Management sold 2,942 Elevance Health shares in Q2 2026, an estimated $1.09M.
- Elevance Health made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #569 holding.
- Erste Asset Management first reported a position in Elevance Health in Q4 2018 and has held it in 31 quarters since.
- Erste Asset Management's Elevance Health position peaked at $9.1M in Q2 2022.
- 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.